{"id":"https://openalex.org/A5024694073","orcid":"https://orcid.org/0009-0000-6483-0925","observed_orcids":["https://orcid.org/0009-0000-6483-0925"],"display_name":"Guillemette de la Borderie","raw_author_names":["G de la Borderie","G. de la Borderie","Guillemette De La Borderie","Guillemette De la Borderie","Guillemette de la Borderie","de la Borderie, Guillemette"],"full_name":"Guillemette de la Borderie","works_count":16,"cited_by_count":384,"summary_stats":{"2yr_mean_citedness":7.625,"h_index":4,"i10_index":3},"ids":{"openalex":"https://openalex.org/A5024694073","orcid":"https://orcid.org/0009-0000-6483-0925","observed_orcids":["https://orcid.org/0009-0000-6483-0925"]},"affiliations":[{"institution":{"id":"https://openalex.org/I1320473756","ror":"https://ror.org/005bvs909","display_name":"The Royal Melbourne Hospital","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1320473756","https://openalex.org/I4210158168"]},"years":[2023]},{"institution":{"id":"https://openalex.org/I2800555584","ror":"https://ror.org/02a8bt934","display_name":"Peter MacCallum Cancer Centre","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]},"years":[2023]},{"institution":{"id":"https://openalex.org/I4210103390","ror":"https://ror.org/01n6t9x28","display_name":"UCB Pharma (France)","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210103390","https://openalex.org/I85722119"]},"years":[2024]},{"institution":{"id":"https://openalex.org/I4210166732","ror":"https://ror.org/05pkeac16","display_name":"UCB Pharma (Germany)","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210166732","https://openalex.org/I85722119"]},"years":[2023]},{"institution":{"id":"https://openalex.org/I85722119","ror":"https://ror.org/01n029866","display_name":"UCB Pharma (Belgium)","country_code":"BE","type":"company","lineage":["https://openalex.org/I85722119"]},"years":[2026,2024,2023]}],"last_known_institutions":[{"id":"https://openalex.org/I85722119","ror":"https://ror.org/01n029866","display_name":"UCB Pharma (Belgium)","country_code":"BE","type":"company","lineage":["https://openalex.org/I85722119"]}],"topics":[{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","count":13,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","count":11,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","count":7,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11730","display_name":"Autoimmune Bullous Skin Diseases","count":5,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","count":2,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","value":0.0001312,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11730","display_name":"Autoimmune Bullous Skin Diseases","value":0.0001083,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","value":5.22e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","value":4.16e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12035","display_name":"Pain Management and Placebo Effect","value":1.73e-05,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"2778105408","wikidata":"https://www.wikidata.org/wiki/Q8285","display_name":"Myasthenia gravis","score":0.9234685897827148},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.907230794429779},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.6365216970443726},{"id":"535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","score":0.4166322946548462},{"id":"121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","score":0.12659892439842224}],"counts_by_year":[{"year":2022,"works_count":0,"oa_works_count":0,"cited_by_count":1},{"year":2023,"works_count":8,"oa_works_count":3,"cited_by_count":32},{"year":2024,"works_count":6,"oa_works_count":5,"cited_by_count":90},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":128},{"year":2026,"works_count":2,"oa_works_count":2,"cited_by_count":133}],"display_name_alternatives":["G de la Borderie","G. de la Borderie","Guillemette De La Borderie","Guillemette De la Borderie","Guillemette de la Borderie","de la Borderie, Guillemette"],"block_key":"g borderie","works_api_url":"https://api.openalex.org/works?filter=author.id:A5024694073","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5024694073","updated_date":"2026-11-12T13:17:38","created_date":"2023-04-15T00:00:00"}
